Scope

Scope Biosciences is a Dutch biotechnology company specializing in the development of next-generation molecular diagnostics using CRISPR-Cas technology. The company's proprietary ScopeDx platform leverages the high specificity and ease of use of CRISPR-Cas enzymes to provide rapid, lab-quality nucleic acid testing outside of traditional laboratory settings. Initially focused on agricultural applications and pathogen detection, the company is expanding its technology into human healthcare and clinical diagnostics. Scope Biosciences aims to revolutionize the point-of-care market by offering highly accurate, field-deployable diagnostic tools that do not require complex thermal cycling.